Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share
Home
Publications
EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share
EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share
Authors:
VH
V Heitlage
V Heitlage
JF
Jf Farley
Jf Farley
RS
R Shah
R Shah
HT
H Tyagi
H Tyagi
DS
D Stenehjem
D Stenehjem
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
25 June 2022
journal article
abstracts
Published by
Elsevier
in
Value in Health
Vol. 25
(7)
,
S460
DOI:
10.1016/j.jval.2022.04.889
Abstract
No abstract available
Keywords
MARKET SHARE
Scroll to top